Literature DB >> 23670109

Reply: The amyloid cascade is not the only pathway to AD.

Gaël Chételat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23670109     DOI： 10.1038/nrneurol.2013.21-c2

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  5 in total

1.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Ronald C Petersen; Michael W Weiner; Paul S Aisen; Leslie M Shaw; Prashanthi Vemuri; Heather J Wiste; Stephen D Weigand; Timothy G Lesnick; Vernon S Pankratz; Michael C Donohue; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2013-02       Impact factor: 44.182

2.  Can tauopathy shake the amyloid cascade hypothesis?

Authors:  Venugopalan Y Vishnu
Journal:  Nat Rev Neurol       Date:  2013-05-14       Impact factor: 42.937

3.  Frequency of stages of Alzheimer-related lesions in different age categories.

Authors:  H Braak; E Braak
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

4.  Brain injury biomarkers are not dependent on β-amyloid in normal elderly.

Authors:  David S Knopman; Clifford R Jack; Heather J Wiste; Stephen D Weigand; Prashanthi Vemuri; Val J Lowe; Kejal Kantarci; Jeffrey L Gunter; Matthew L Senjem; Michelle M Mielke; Rosebud O Roberts; Bradley F Boeve; Ronald C Petersen
Journal:  Ann Neurol       Date:  2013-02-19       Impact factor: 10.422

5.  Alzheimer disease: Aβ-independent processes-rethinking preclinical AD.

Authors:  Gaël Chételat
Journal:  Nat Rev Neurol       Date:  2013-02-12       Impact factor: 42.937
  5 in total
  4 in total

Review 1.  Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings.

Authors:  Meredith N Braskie; Paul M Thompson
Journal:  Trends Cogn Sci       Date:  2013-09-09       Impact factor: 20.229

Review 2.  Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer's Disease.

Authors:  Barbara Mroczko; Magdalena Groblewska; Ala Litman-Zawadzka; Johannes Kornhuber; Piotr Lewczuk
Journal:  Int J Mol Sci       Date:  2018-06-27       Impact factor: 5.923

Review 3.  Multimodal Neuroimaging in Alzheimer's Disease: Early Diagnosis, Physiopathological Mechanisms, and Impact of Lifestyle.

Authors:  Gaël Chételat
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 4.  The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer's Disease (AD).

Authors:  Barbara Mroczko; Magdalena Groblewska; Ala Litman-Zawadzka
Journal:  Int J Mol Sci       Date:  2019-09-20       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.